What is mi profile testing?

MI Profile is a multi-platform, solid tumor biomarker analysis for therapeutic decision support and clinical trials matching.

What is Caris testing?

Caris Molecular Intelligence performs comprehensive molecular testing on the DNA, RNA and Proteins to identify the biomarkers driving a patient’s tumor. This information may be a powerful tool to aid oncologists in personalizing cancer therapies for their patients.

Is Caris MI profile FDA approved?

Caris Molecular Intelligence has not been approved by the United States Food and Drug Administration. Please consult your physician to determine if Caris Molecular Intelligence® is right for you.

Does Caris offer liquid biopsy?

“We are excited to partner with ESSA to expand the reach of Caris’ best-in-class liquid biopsy offering, assessing all 22,000 genes in both DNA and RNA, which are unique to an individual’s cancer,” said Brian Lamon, Chief Business Officer at Caris Life Sciences.

What is Tempus xT panel?

The Tempus xT oncology assay combines a 648-gene DNA sequencing panel with whole-transcriptome RNA sequencing to detect clinically actionable gene variants in both solid tumors and hematologic malignancies.

Who owns Caris Life?

Chairman and Chief Executive Officer David D. Halbert is a proven leader with a strong track record of growth and value creation in the energy, financial and healthcare industries. With more than 40 years of experience, Mr. Halbert continues to be one of the most successful entrepreneurs in this country.

Is Caris CLIA certified?

Along with ISO 15189 accreditation, Caris has also earned accreditation from Clinical Laboratory Improvement Amendments (CLIA), as well as an extensive list of certifications from the state of New York.

What does Caris Life science do?

Caris Life Sciences® (Caris) is a molecular science company developing and delivering technologies to revolutionize healthcare. Caris is also advancing precision medicine through advanced artificial intelligence (AI) and machine learning algorithms.

What is Tempus xF?

xF is Tempus’ non-invasive, 105-gene liquid biopsy panel focused on oncogenic and resistance mutations in cell-free DNA.

Is Tempus xT FDA approved?

Tempus, a leader in artificial intelligence and precision medicine, today announced the submission of a Premarket Approval (PMA) application for its proprietary broad-panel DNA sequencing assay to the U.S. Food and Drug Administration (FDA).

What is genomic profiling?

Listen to pronunciation. (jeh-NOH-mik PROH-fy-ling) A laboratory method that is used to learn about all the genes in a person or in a specific cell type, and the way those genes interact with each other and with the environment.

What does Caris stand for?

CARIS